课题基金 / 基金详情

CLINICOPATHOLOGIC STUDIES FOR HISTOLOGICAL CLASSIFICATION AND PROGNOSIS OF RHABDOMYOSARCOMA

CLINICOPATHOLOGIC STUDIES FOR HISTOLOGICAL CLASSIFICATION AND PROGNOSIS OF RHABDOMYOSARCOMA
横纹肌肉瘤组织学分类和预后的临床病理学研究
批准号:
10670187
负责人:
HASEGAWA Tadashi
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

HASEGAWA Tadashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) We reviewed 6 cases of rhabdomyosarcoma as a rare second primary malignancy in children with bilateral retinoblastoma after irradiation treatment. We have concluded that knowledge of the occurrence of rhabdomyosarcoma and appropriate immunohistochemical study are helpful for avoiding a misdiagnosis of recurrent retinoblastoma or Ewing's sarcoma when encountering these patients who developed second small round cell neoplasms.2) We studied immunoreactivity for E-cadherin, the major cadherin of epithelial cells, in 77 cases of a variety of bone and soft tissue sarcomas. We found that E-cadherin was expressed in certain kinds of soft tissue sarcomas, especially those with epithelioid features, suggesting that E-cadherin plays a role in the constitution of their architecture.3) We conducted clinicopathologic study for 24 cases of extrathoracic solitary fibrous tumor that should be differentiated from spindle cell rhabdomyosarcoma, and found their histological variability and potentially aggressive behavior.4) We investigated the prognostic relevance of a histological grading system based on the assessment of proliferative activity in 95 cases of adult soft-tissue sarcomas including 3 rhabdomyosarcomas of the extremities, trunk, head, and neck. An objective histological grading system using ki-67 (MIB-1) was concluded to be more accurate in accessing ability to metastasize, which was strongly correlate with overall survival.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Tadashi Hasegawa et al.: "Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma"Oncology. 58. 66-74 (2000)
Tadashi Hasekawa 等人:“使用 MIB-1 的组织学分级系统对成人软组织肉瘤的预后相关性”肿瘤学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tadashi Hasegawa et al.: "Second primary rhabdomysarcomas in patients with bilateral retinoblastoma : a clinicopathologic and immunohistochenical study"Am J sung Pathol. 22. 1351-1360 (1998)
Tadashi Hasekawa 等人:“双侧视网膜母细胞瘤患者的第二原发性横纹肌肉瘤:临床病理学和免疫组织化学研究”Am J sung Pathol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Haruhiro Sato,Tadashi Hasegawa et al.: "Expression of E-cadherin in bone and soft tissue sarcomas : a possible role in epithelial differentiation"Hum Pathol. 30. 1344-1349 (1999)
Haruhiro Sato、Tadashi Hasekawa 等人:“E-钙粘蛋白在骨和软组织肉瘤中的表达:在上皮分化中的可能作用”Hum Pathol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Haruhiro Sato, Tadashi Hasegawa, et al.: "Expression of E-cadherin in Bone and Soft Tissue Sarcomas : A Possible Role in Epithelial Differentiation"Human Pathology. 30(11). 1344-1349 (1999)
Haruhiro Sato、Tadashi Hasekawa 等人:“E-钙粘蛋白在骨和软组织肉瘤中的表达:在上皮分化中的可能作用”人类病理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Development of teacher training programs for nurturing children's scientific thinking
    • 批准号:
      19H01665
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2019
    • 负责人:
      HASEGAWA Tadashi
    • 依托单位:
    A standard curriculum for science education in primary school teacher training
    • 批准号:
      22300269
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2010
    • 负责人:
      HASEGAWA Tadashi
    • 依托单位:
    A cultivation of science teacher with qualities of science communicator and proposed support system for scientific experiment
    • 批准号:
      18300262
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.06万
    • 财政年份:
      2006
    • 负责人:
      HASEGAWA Tadashi
    • 依托单位:
    FISH analysis for EWSR1 gene rearrangement in Ewing sarcoma/PNET
    • 批准号:
      17590327
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      2005
    • 负责人:
      HASEGAWA Tadashi
    • 依托单位:
    国内基金
    海外基金
    植物RETINOBLASTOMA-RELATED (RBR)蛋白网络调控根尖干细胞损伤修复的分子机制
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      58万元
    • 批准年份:
      2020
    • 负责人:
      周文焜
    • 依托单位:
    植物RETINOBLASTOMA-RELATED (RBR)蛋白网络调控根尖干细胞损伤修复的分子机制
    • 批准号:
      32070874
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      周文焜
    • 依托单位:
    Prohibitin通过与Retinoblastoma蛋白相互作用参与E2F细胞周期调控途径的分子机制
    • 批准号:
      31300635
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      22.0万元
    • 批准年份:
      2013
    • 负责人:
      宣劲松
    • 依托单位: